Fibromyalgia Trial, Recruiting NCT07048366 Sponsor: G. d'Annunzio University Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07048366
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are female
  • You have been diagnosed with Fibromyalgia Syndrome using the 2016 diagnostic criteria
  • Your muscle pain has been rated higher than 5 out of 10 on a pain scale over the last month
  • You are between 18 and 60 years old
  • You do not have any other long-term or widespread pain conditions
  • You do not have any other health condition that could affect how you feel pain (for example, diabetes)
  • You do not have any neurological or psychiatric conditions that could affect your ability to take part in the study
  • You have not had cancer in the last 5 years
  • You have not taken steroid medications (corticosteroids) in the last 30 days
  • You have not taken anti-inflammatory or painkiller medications in the last 4 days
  • You are not pregnant or breastfeeding, and will not become pregnant or breastfeed during the study
  • You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • You have severe curvature of the spine (such as scoliosis or kyphoscoliosis)
  • You have had surgery on your spine, or have lasting effects from a spinal fracture
  • You currently have sciatica-like pain (pain spreading from your lower back down your leg)
  • You have osteoporosis (weakened, fragile bones)
  • You have a neurological or psychiatric condition
  • You are currently taking steroids, anti-inflammatory drugs, or painkillers
  • You are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Teresa Paolucci, Associate Professor, MD, PhD, University of Study "G. d'Annunzio" of Chieti-Pescara

Phone: +39 3479338625

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
G. d'Annunzio University
Registry
ClinicalTrials.gov
Start date
27 November 2025
Est. completion
31 July 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Pain Reduction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov